Meridian Venture Partners II GP, L.P. - 21 Aug 2025 SCHEDULE 13D/A Report for ANI Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ANIP)

Filing Manager: Meridian Venture Partners II GP, L.P.
Reporting Manager: Robert E. Brown, Jr.
Security: ANI Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol: ANIP
Shares outstanding: 21,553,542 shares
Disclosed Ownership: 1,034,570 shares
Ownership: 4.8%
Form type: SCHEDULE 13D/A
Filing time: 22 Aug 2025, 08:00:22 UTC
Date of event: 21 Aug 2025
Previous filing: 13 Mar 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Meridian Venture Partners II GP, L.P. ("GP")	4.7%	1,014,381	0	1,014,381	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001580170
Meridian Venture Partners II, L.P.	4.7%	1,014,381	0	1,014,381	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001109507
Meridian Venture Partners II, Co.	4.7%	1,014,381	0	1,014,381	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001580169
Robert E. Brown, Jr.	4.8%	1,034,570	20,189	1,014,381	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001579672